Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

Ma, Jianyi, Yee, Ann, Brewer, H. Bryan, Das, Saumya, Potter, Huntington·1994·Nature
DOI 10.1038/372092a0

Cited by (869)

Items 401–500 of 869

  1. Modulation of Aβ Deposition in APP Transgenic Mice by an Apolipoprotein E Null Background
    IRIZARRY, M. C., REBECK, G. W., CHEUNG, B., BALES, K., PAUL, S. M, HOLZMAN, D., HYMAN, B. T. · 2000 · Annals of the New York Academy of Sciences
  2. Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease
    Huntington Potter, Antoneta Granic, Julbert Caneus · 2015 · Current Alzheimer Research
  3. ROLE OF MACROPHAGES IN ACETAMINOPHEN (PARACETAMOL)-INDUCED HEPATOTOXICITY
    Robert David Goldin, Indrika Ratnayaka, C. S. BREACH, Ivor N. Brown, S. N. Wickramasinghe · 1996 · The Journal of Pathology
  4. Cerebral amyloid angiopathies.
    Francisco Coria, I. Rubio · 1996 · PubMed
  5. Risky apolipoprotein in brain
    Michel Goedert, Warren J. Strittmatter, Allen D. Roses · 1994 · Nature
  6. Distribution of the Native Strain in Human α1-Antitrypsin and Its Association with Protease Inhibitor Function
    Eun Joo Seo, Ha Na Im, Jin-Soo Maeng, Kyoon Eon Kim, Myeong‐Hee Yu · 2000 · Journal of Biological Chemistry
  7. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, Gelsolin and AA amyloids
    Claudio A. Soto, Eduardo Miguel Castaño, Frances C. Prelli, Rashmi Kumar, Marc Baumann · 1995 · FEBS Letters
  8. On the metabolism of apolipoprotein E and the Alzheimer diseases
    Allen D. Roses · 1995 · Experimental Neurology
  9. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case–Control Study
    Zhipeng Xu, Sulian Yang, Shi Zhao, Chenghong Zheng, Honghua Li, Yao Zhang, Rongxi Huang, Mengzhu Li, Yuan Gao, Shujuan Zhang et al. · 2016 · EBioMedicine
  10. Brain Amyloid — A Physicochemical Perspective
    John E. Maggie, Patrick W. Mantyh · 1996 · Brain Pathology
  11. A specific structural interaction of Alzheimer's peptide Aβ1–42 with α1-antichymotrypsin
    Sabina M Janciauskiene, Sten Eriksson, H.T. Wright · 1996 · Nature Structural & Molecular Biology
  12. Molecular and cellular mediators of Alzheimer's disease inflammation
    Ron Strohmeyer, Joseph Rogers · 2001 · Journal of Alzheimer s Disease
  13. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides
    Gianluigi Forloni, Fabrizio Tagliavini, Orso Bugiani, Mario Salmona · 1996 · Progress in Neurobiology
  14. Blocking the Apolipoprotein E/Amyloid-β Interaction Reduces Fibrillar Vascular Amyloid Deposition and Cerebral Microhemorrhages in TgSwDI Mice
    Jing Yang, Yong Ji, Pankaj D Mehta, Kristyn Alissa Bates, Yanjie Sun, Thomas Wısnıewskı · 2011 · Journal of Alzheimer s Disease
  15. Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival
    Adriano Ferrucci, Michael R. Nonnemacher, Brian L. Wigdahl · 2013 · Journal of NeuroVirology
  16. The Genetics of Dementia With Lewy Bodies
    Bram Meeus, Jessie Theuns, Christine Van Broeckhoven · 2012 · Archives of Neurology
  17. Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease
    Donald J. Lehmann, Zsuzsanna Nagy, S. Litchfield, Mario Cortina‐Borja, A. David Smith · 2000 · Human Genetics
  18. Alzheimer's disease: molecular concepts and therapeutic targets
    Klaus C Fassbender, Colin Louis Masters, Konrad T. Beyreuther · 2001 · Die Naturwissenschaften
  19. Association of apolipoprotein ?4 allele and neuropathologic findings in patients with dementia
    Maria‐Grazia Martinoli, John Q. Trojanowski, M. L. Schmidt, Steven Edward Arnold, Takuya Fujiwara, V. M. -Y. Lee, Howard I. Hurtig, Jean‐Pierre Julien, Cecilia N. Clark · 1995 · Acta Neuropathologica
  20. Molecular biology of APO E alleles in Alzheimer’s and non-Alzheimer’s dementias
    Christopher M. Morris, H. M. Massey, R. Benjamin, Alan Leake, C. Broadbent, Martin Griffiths, Helen Lamb, Andrew John Brown, Paul G. Ince, Stephen Patrick Tyrer et al. · 1996 · Journal of neural transmission. Supplementum
  21. Genetic Ablation of Apolipoprotein A-IV Accelerates Alzheimer's Disease Pathogenesis in a Mouse Model
    Yujie Cui, Mingwei Huang, Yingbo He, Shuyan Zhang, Yongzhang Luo · 2011 · American Journal Of Pathology
  22. Reelin and apoE actions on signal transduction, synaptic function and memory formation
    Justin T. Rogers, Edwin J. Weeber · 2008 · Neuron Glia Biology
  23. Anti-inflammatory drugs: a hope for Alzheimer’s disease?
    Michael Hüll, Klaus Lieb, Bernd L. Fiebich · 2000 · Expert Opinion on Investigational Drugs
  24. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models
    Yadong Huang · 2011 · Biochemical Society Transactions
  25. Cholesterol and apolipoprotein E in Alzheimer's disease
    Allison Bethanne Reiss · 2005 · American Journal of Alzheimer s Disease & Other Dementias®
  26. Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system
    Philip Wulf, Robert R. Bernhardt, Ueli Suter · 1999 · Journal of Neuroscience Research
  27. Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice.
    Mark S. Kindy, Daniel James Rader · 1998 · Europe PMC (PubMed Central)
  28. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside
    Walia, Vaibhav, Kaushik, Deepak, Mittal, Vineet, Kumar, Kuldeep, Verma, Ravinder, Parashar, Jatin, Akter, Rokeya, Rahman, Md. Habibur, Bhatia, Saurabh, Al-Harrasi, Ahmed et al. · 2022 · Molecular Neurobiology
  29. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer’s transgenic mouse lines differing in Aβ deposition
    Ralph E. Leighty, Lars N. G. Nilsson, Huntington Potter, David A. Costa, Mark A Low, Kelly R. Bales, Steven M. Paul, Gary W. Arendash · 2004 · Behavioural Brain Research
  30. The neurochemistry of Alzheimer's disease
    Kaj Blennow, Richard F. Cowburn · 1996 · Acta Neurologica Scandinavica
  31. TREATMENT OF ALZHEIMER'S DISEASE
    Michael Grundman, Leon J. Thal · 2000 · Neurologic Clinics
  32. Prevention of Amyloid-Like Deposition by a Selective Prolyl Endopeptidase Inhibitor, Y-29794, in Senescence-Accelerated Mouse
    Akira Kato, Atsushi Fukunari, Yoko Sakai, Tohru Nakajima · 1997 · Journal of Pharmacology and Experimental Therapeutics
  33. Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice
    Christian Lesuisse · 2001 · Human Molecular Genetics
  34. APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology
    Barry Greenberg, Mary J. Savage, David Howland, Shujath M. Ali, Sandra L. Siedlak, George L. Perry, Robert Siman, Richard W. Scott · 1996 · Neurobiology of Aging
  35. Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins
    Asha Naidu, Qiang Xu, Rosanne Catalano, Barbara Cordell · 2002 · Brain Research
  36. Endosome-Lysosomes, Ubiquitin and Neurodegeneration
    R. John Mayer, Carron Tipler, Jane Arnold, Lajos László, Abdulaziz Ali Al-Khedhairy, James S Lowe, Michael Landon · 1996 · Advances in experimental medicine and biology
  37. Alzheimer Amyloid-β Peptide Forms Denaturant-Resistant Complex with Type ε3 but Not Type ε4 Isoform of Native Apolipoprotein E
    Zhongmin Zhou, Jonathan D. Smith, Paul Greengard, Sam Gandy · 1996 · Molecular Medicine
  38. Androgens, ApoE, and Alzheimer's Disease
    Jacob Raber · 2004 · Science of Aging Knowledge Environment
  39. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with β-amyloid-(1–40): the role of salt bridges
    Nicholas M. Bentley, Mary Jo LaDu, Chandrika Rajan, Godfrey S. Getz, Catherine A. Reardon · 2002 · Biochemical Journal
  40. Functional characterization of three single‐nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA–protein interactions
    Bryan Maloney, Yuan‐Wen Ge, Ronald Carl Petersen, John Hardy, Jack T. Rogers, Jordi Pérez‐Tur, Debomoy K. Lahiri · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  41. CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.
    Jorge A. Ghiso, Yasushi Tomidokoro, Tamás Révész, Blas Frangione, Agueda A. Rostagno · 2010 · PubMed
  42. Hereditary cerebral hemorrhage with amyloidosis dutch type (AβPP 693): decreased plasma amyloid-β 42 concentration
    Marjolijn Bornebroek, Chris De Jonghe, Joost Haan, Samir Kumar‐Singh, Steve Younkin, Raymund A.C. Roos, Christine Van Broeckhoven · 2003 · Neurobiology of Disease
  43. Plug‐Based Microfluidics with Defined Surface Chemistry to Miniaturize and Control Aggregation of Amyloidogenic Peptides
    Matthias Meier, Julia Kennedy‐Darling, Se Hoon Choi, Eric M. Norstrom, Sangram S. Sisodia, Rustem F. Ismagilov · 2009 · Angewandte Chemie International Edition
  44. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide
    Nancy C. Stratman, Christine K. Castle, Bruce M. Taylor, Dennis E. Van Epps, George W. Melchior, Donald B. Carter · 2005 · Chemistry and Physics of Lipids
  45. Brain oestradiol and testosterone levels in Alzheimer's disease
    Samantha J Twist, Geoffrey A. Taylor, Ann Weddell, David R. Weightman, James Alexander Edwardson, Christopher M. Morris · 2000 · Neuroscience Letters
  46. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression
    Jin G. Sheng, R E Mrak, W. Sue T. Griffin · 1996 · Neuropathology and Applied Neurobiology
  47. Lack of association of the α2-macroglobulin locus on chromosome 12 in AD
    ALISON M. GIBSON, Andrew Singleton, G. Smith, Rebecca Woodward, Ian Grant McKeith, R.H. Perry, Paul G. Ince, Clive G. Ballard, James Alexander Edwardson, Christopher M. Morris · 2000 · Neurology
  48. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer’s Disease Pathogenesis
    Carla Borràs, Aina Mercer, Sònia Sirisi, Daniel Andres Alcolea, Joan Carles Escolá‐Gil, Francisco Blanco‐Vaca, Mireia Tondo · 2022 · International Journal of Molecular Sciences
  49. Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
    Thomas Wısnıewskı, Martin J. Sadowski · 2008 · BMC Neuroscience
  50. Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis
    Torbjörn Persson, Francesca Lattanzio, Javier Calvo‐Garrido, Roberto Rimondini, Marta Rubio-Rodrigo, Erik Sundström, Silvia Maioli, Anna Matton, Ángel Cedazo-Mı́nguez · 2016 · Journal of Alzheimer s Disease
  51. Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls
    Pirttilä, T., Soininen, H., Heinonen, O., Lehtimäki, T., Bogdanovic, N., Paljärvi, L., Kosunen, O., Winblad, B., Riekkinen, P., Wisniewski, H.M. et al. · 1996 · Brain Research
  52. Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease
    Federico Licastro, Steve Pedrini, Marzia Govoni, Annalisa Pession, Cinzia Ferri, Giorgio Annoni, Valeria M. Casadei, Fabrizio Veglia, Stefano Bertolini, Luigi M.E. Grimaldi · 1999 · Neuroscience Letters
  53. Chemical Cross-Linking/Mass Spectrometry Maps the Amyloid β Peptide Binding Region on Both Apolipoprotein E Domains
    Stéphanie Deroo, Florian Stengel, Azadeh Mohammadi, Nicolas Henry, Ellen Hubin, Eva‐Maria Krammer, Ruedi H. Aebersold, Vincent Raussens · 2014 · ACS Chemical Biology
  54. Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?
    Md. Mahiuddin Ahmed, Noah R. Johnson, Timothy D. Boyd, Christina M. Coughlan, Heidi J. Chial, Huntington Potter · 2021 · Frontiers in Aging Neuroscience
  55. An ApoE-Aβ inhibition complex in Aβ fibril extension
    Stephen J. Wood, Winnie Chan, Ronald B. Wetzel · 1996 · Chemistry & Biology
  56. Enhanced levels of scrapie responsive gene mRNA in BSE-infected mouse brain
    Françoise Dandoy‐Dron, Louisa Benboudjema, Frédéric Guillo, Alexandre Jaegly, C Jasmin, Dominique Dormont, Michaël G. Tovey, Michel Dron · 2000 · Molecular Brain Research
  57. Molecular Aspects of Inflammatory and Immune Responses in Alzheimer's Disease
    Raj N. Kalaria, M. Harshbarger-Kelly, David Cohen, Daniel R. Premkumar · 1996 · Neurobiology of Aging
  58. Genetic variation in α1-antichymotrypsin and its association with Alzheimer’s disease
    Xiaoyan Wang, Steven Trent DeKosky, Erin Luedecking‐Zimmer, Mary Ganguli, M. Ilyas Kamboh · 2002 · Human Genetics
  59. α-1-Antichymotrypsin interaction with Aβ (1–40) inhibits fibril formation but does not affect the peptide toxicity
    Marina V Aksenova, Michael Y. Aksenov, David Allan Butterfield, John M. Carney · 1996 · Neuroscience Letters
  60. Therapeutic approaches for prion and Alzheimer's diseases
    Thomas Wısnıewskı, Einar M. Sigurdsson · 2007 · FEBS Journal
  61. APOE ε4 allele and CSF APOE on Cognition in HIV-Infected Subjects
    Marilou A. Andres, Ute Feger, Avindra Nath, Sody Mweetwa Munsaka, Caroline S. Jiang, Linda Chang · 2010 · Journal of Neuroimmune Pharmacology
  62. Genes Involved in the Balance between Neuronal Survival and Death during Inflammation
    Isaías Glezer, Ariel Chernomoretz, Samuel David, Marie-Michèle Plante, Serge Rivest · 2007 · PLoS ONE
  63. Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference
    Peter Schubert, Tadanori Ogata, Hirofumi Miyazaki, Cristina Marchini, Stefano Ferroni, Karl Asmund Rudolphi · 1998 · Journal of neural transmission. Supplementum
  64. High‐affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid‐β
    Shamasree Ghosh, Timir Baran Sil, Subhrajyoti Dolai, Kanchan Garai · 2019 · FEBS Journal
  65. Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background
    Federico Licastro · 2003 · Mechanisms of Ageing and Development
  66. Cerebral amyloid angiopathies
    Francisco Coria, I. Rubio · 1996 · Neuropathology and Applied Neurobiology
  67. CSF beta‐amyloid 1–42 – what are we measuring in Alzheimer's disease?
    William T. Hu, Kelly D. Watts, Leslie M. J. Shaw, Jennifer Christina Howell, John Q. Trojanowski, Sundeep S. Basra, Jonathan D. Glass, James J. Lah, Allan I. Levey · 2014 · Annals of Clinical and Translational Neurology
  68. Apolipoprotein E Genotype and Response of Carbon Monoxide Poisoning to Hyperbaric Oxygen Treatment
    Ramona O. Hopkins, Lindell K. Weaver, Karen J. Valentine, Chrissa P. Mower, Susan K Churchill, John F. Carlquist · 2007 · American Journal of Respiratory and Critical Care Medicine
  69. Search for Amyloid-Binding Proteins by Affinity Chromatography
    Miguel Calero, Agueda A. Rostagno, Jorge A. Ghiso · 2012 · Methods in molecular biology
  70. The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects
    Mari Niemi, Kari Kervinen, Asko O. Rantala, Heikki Kauma, Markku J. Päivänsalo, Markku J. Savolainen, Mauno Lilja, Y. Antero Kesäniemi · 1999 · Gut
  71. Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer’s disease
    François Torreilles, Jacques Touchon · 2002 · Progress in Neurobiology
  72. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians
    Morris, C.M., Benjamin, R., Leake, A., McArthur, F.K., Candy, J.M., Ince, P.G., Torvik, A., Bjertness, E., Edwardson, J.A. · 1995 · Neuroscience Letters
  73. Association of α1‐antichymotrypsin polymorphism with cerebral amyloid angiopathy
    Masahito Yamada, Nobuyuki Sodeyama, Yoshinori Itoh, Naomi Suematsu, Eiichi Otomo, Masaaki Matsushita, Hidehiro Mizusawa · 1998 · Annals of Neurology
  74. Engineering Conformational Destabilization into Mouse Apolipoprotein E
    Danny M. Hatters, Clare A. Peters-Libeu, Karl Heinrich Weisgraber · 2005 · Journal of Biological Chemistry
  75. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer’s disease.
    Dickson, T. C., Saunders, H. L., Vickers, J. C. · 1997 · Neuropathology and Applied Neurobiology
  76. Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease
    Emamzadeh, Fatemeh Nouri, Aojula, Harmesh, McHugh, Patrick C., Allsop, David · 2016 · Neuroscience Letters
  77. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β
    Amanda B. Chai, Hin Hei Julian Lam, Maaike Kockx, Ingrid C. Gelissen · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  78. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer’s disease
    Federico Licastro, Martina Chiappelli, Luigi M. E. Grimaldi, Kevin Morgan, Noor A Kalsheker, Elena Calabrese, Alistair Ritchie, Elisa Porcellini, Giuliana Salani, M. Franceschi et al. · 2004 · Neurobiology of Aging
  79. Association between presenilin-1 polymorphism and maternal meiosis II errors in Down syndrome
    Michael Bjorn Petersen, Georgia Karadima, Maria Samaritaki, Dimitrios Avramopoulos, Dimitris Vassilopoulos, Margareta Mikkelsen · 2000 · American Journal of Medical Genetics
  80. Molecular Neurobiology of Alzheimer's Disease (Syndrome?)
    George S. Zubenko · 1997 · Harvard Review of Psychiatry
  81. Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the A‚-containing lesions in brains of patients with dementia of the Alzheimer type
    Marcel M. Verbeek, Irene Otte‐Höller, Pieter Wesseling, Dirk J. Ruiter, Robert M.W. de Waal · 1996 · Acta Neuropathologica
  82. Biological basis for amyloidogenesis in Alzheimer’S disease
    Т. В. Андреева, Walter J. Lukiw, Evgeny Ivanovich Rogaev · 2017 · Biochemistry (Moscow)
  83. Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden
    Zixuan Lin, Sandeepa Sur, Anja Soldan, Corinne A. Pettigrew, Michael I. Miller, Kenichi Oishi, Murat Bilgel, Abhay Moghekar, Jay J. Pillai, Marilyn Albert et al. · 2019 · Radiology
  84. Transthyretin Accelerates Vascular Aβ Deposition in a Mouse Model of Alzheimer's Disease
    Henny Wati, Takeshi Kawarabayashi, Etsuro Matsubara, Ayumi Kasai, Takae Hirasawa, Takeo Kubota, Yasuo Harigaya, Mikio Shoji, Shuichiro Maeda · 2008 · Brain Pathology
  85. Interaction between human amphipathic apolipoproteins and amyloid β‐peptide: surface plasmon resonance studies
    Vladimir V. Shuvaev, Gérard Siest · 1996 · FEBS Letters
  86. A Protective Effect of Apolipoprotein E e2 Allele on Dementia in Down’s Syndrome
    Janette Tyrrell, Mary Cosgrave, Ziarih Hawi, Janet McPherson, Catherine Adell O'Brien, John McCalvert, Martin McLaughlin, BRIAN A. LAWLOR, Michael Gill · 1998 · Biological Psychiatry
  87. Biological Markers in Alzheimer Disease
    Judith A. Neugroschl, Kenneth L. Davis · 2002 · American Journal of Geriatric Psychiatry
  88. The Functions of the Amyloid Precursor Protein Gene
    Peter K. Panegyres · 2001 · Reviews in the Neurosciences
  89. The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer s disease
    Huntington Potter · 1998 · Frontiers in bioscience
  90. Early amyloid -β deposits show different immunoreactivity to the amino- and carboxy-terminal regions of β-peptide in Alzheimer's disease and Down's syndrome brain
    Elizabeth Kida, Krystyna E. Wisniewski, Henryk M. Wı́sniewski · 1995 · Neuroscience Letters
  91. Apolipoprotein E deposition and astrogliosis are associated with maturation of β-amyloid plaques in βAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer’s disease
    Kazuhiro Terai, Akihiko Iwai, Shigeki Kawabata, Masao Sasamata, Keiji Miyata, Tokio Yamaguchi · 2001 · Brain Research
  92. Astroglial localization of cholesteryl ester transfer protein in normal and Alzheimer's disease brain tissues
    Tōru Yamada, M. Kawata, Hiroyuki Arai, Masayoshi Fukasawa, Kenichi Inoue, Toshitaka Sato · 1995 · Acta Neuropathologica
  93. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease
    John Hardy · 1995 · American Journal of Medical Genetics
  94. Apolipoprotein E and Alzheimer's disease: a genetic, molecular and neuroimaging review.
    Richard H. Swartz, Sandra E. Black, Peter St George‐Hyslop · 1999 · PubMed
  95. Amyloid β-Peptide-induced Inhibition of MTT Reduction in PC12h and C1300 Neuroblastoma Cells: Effect of Nitroprusside
    Takato Takenouchi, Eisuke Munekata · 1998 · Peptides
  96. Synthesis of membrane- and matrix-bound colony-stimulating factor-1 by cultured osteoblasts
    R. Felix, Judit Halasy-Nagy, Antoinette Wetterwald, Marco G. Cecchini, Herbert André Fleisch, Willy Hofstetter · 1996 · Journal of Cellular Physiology
  97. Molecular interactions in the formation and deposition of β2-microglobulin-related amyloid fibrils
    Hironobu Naiki, Suguru Yamamoto, Kazuhiro Hasegawa, Itaru Yamaguchi, Yuji Goto, Fumitake Gejyo · 2005 · Amyloid
  98. NF-κB mediates amyloid β peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells
    Yan-Sheng Du, Xianming Chen, Xing-Lin Wei, K. Bales, D. Berg, S. Paul, M. Farlow, Bryan Maloney, Yuan-Wen Ge, D. Lahiri · 2005 · Molecular Brain Research
  99. Diet and Age Interactions with Regards to Cholesterol Regulation and Brain Pathogenesis
    Romina María Uranga, Jeffrey N. Keller · 2010 · Current Gerontology and Geriatrics Research
  100. The Amyloid Peptide and Its Precursor in Alzheimer's Disease
    Jean Noël Octave · 1995 · Reviews in the Neurosciences